Markets.com Logo

C4X

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --$
  • Previous Close
    --$
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

C4X Discovery Holdings plc (C4X.MU) is a UK-based drug discovery company focused on developing small-molecule medicines, primarily for inflammation and immunology, oncology, and neurodegenerative diseases. They utilize proprietary technologies to identify novel drug targets and generate innovative drug candidates with the goal of out-licensing or partnering these programs with pharmaceutical companies for further development and commercialization. The company is listed on the Euronext Access Paris market.

Factors

Drug Development Progress: Positive clinical trial results typically drive the stock price higher, while failures can cause significant declines.

Regulatory Approval: FDA or EMA approval of a C4X Discovery drug is a major catalyst that can substantially increase the stock's value.

Market Sentiment: General investor optimism or pessimism toward the biotech sector influences trading activity and can affect the share price.

Partnerships and Licensing: Collaborations with larger pharmaceutical companies often lead to upfront payments and potential future royalties, positively impacting the stock.

Financial Performance: C4X Discovery's cash position, burn rate, and ability to raise capital are crucial factors for investors to consider.

People Also Watch

Latest news

Morning Note: Dollar Climbs on Mideast Tensions; Oil Dips; Accenture Q3

Tommy Yap|--

BTCUSD Analysis: Bitcoin Price Dropped Amid Iran-Israel Tensions

Frances Wang|--

Morning Note: Stablecoin Boom on Senate Bill; SNB and BoE Rate Decisions Awaited

Tommy Yap|--

Latest Education Articles

Snap stock analysis: What is the price target for Snap in 2025?

Ghko B|--

Forex market today: USD/INR gains on Middle East tensions

Frances Wang|--

Eli Lilly Stock (LLY) Sinks: What Are Affecting LLY Stock Prices?

Frances Wang|--